跳至主要内容
临床试验/ACTRN12624000663550
ACTRN12624000663550尚未招募3 期

on-antibiotic modulation of small intestinal dysbiosis with oral simethicone as a treatment for patients with disorders of gut-brain interaction: a randomised placebo-controlled trial

Metro South Hospital and Health Service0 个研究点目标入组 192 人开始时间: 2024年5月24日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
192

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1)H. pylori negative patients with a diagnosis of a DGBI (Rome IV criteria) with a negative diagnostic work-up for organic disease.
  • 2)Only patients routinely undergoing gastrointestinal endoscopies for the diagnostic work-up of otherwise unexplained gastrointestinal symptoms will be recruited.
  • 3)Over 18 years of age

排除标准

  • 1)unsuitable for therapy due to any medical conditions, drug allergies or inability to attend follow-up appointments
  • 2)undergoing psychiatric treatment (e.g., full doses of antipsychotic, anxiolytic or antidepressant medication)
  • 3)insufficient language or literacy skills
  • 4)antibiotic use in the previous 3 months.
  • 5)unable to give informed consent

研究者

相似试验